Molecular Mimicry of Human Cytokine and Cytokine Response Pathway Genes by KSHV

Four virus proteins similar to two human macrophage inflammatory protein (MIP) chemokines, interleukin-6 (IL-6), and interferon regulatory factor (IRF) are encoded by the Kaposi's sarcoma-associated herpesvirus (KSHV) genome. vIL-6 was functional in B9 proliferation assays and primarily expressed in KSHV-infected hematopoietic cells rather than KS lesions. HIV-1 transmission studies showed that vMIP-I is similar to human MIP chemokines in its ability to inhibit replication of HIV-1 strains dependent on the CCR5 co-receptor. These viral genes may form part of the response to host defenses contributing to virus-induced neoplasia and may have relevance to KSHV and HIV-I interactions.

[1]  W. B. Smith,et al.  A Role for Endothelial NO Synthase in LTP Revealed by Adenovirus-Mediated Inhibition and Rescue , 1996, Science.

[2]  R. Weiss,et al.  Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry , 1996, Journal of virology.

[3]  P. Moore,et al.  Body Cavity-Based Malignant Lymphoma Containing Kaposi Sarcoma-Associated Herpesvirus in an HIV-Negative Man with Previous Kaposi Sarcoma , 1996, Annals of Internal Medicine.

[4]  E. Cesarman,et al.  Kaposi's sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi's sarcoma and malignant lymphoma , 1996, Journal of virology.

[5]  P. Simmonds,et al.  Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen , 1996, The Lancet.

[6]  J. Levy,et al.  Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients , 1996, The Lancet.

[7]  E. Koonin,et al.  Genome Sequence of a Human Tumorigenic Poxvirus: Prediction of Specific Host Response-Evasion Genes , 1996, Science.

[8]  C. Boshoff,et al.  Cyclin encoded by KS herpesvirus , 1996, Nature.

[9]  J. O’Leary,et al.  Seeking the cause of Kaposi's sarcoma , 1996, Nature Medicine.

[10]  E. Operskalski,et al.  The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma–associated herpesvirus): Distribution of infection in KS risk groups and evidence for sexual transmission , 1996, Nature Medicine.

[11]  J. Phair,et al.  Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. , 1996, The New England journal of medicine.

[12]  W. Zhong,et al.  Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[13]  Virginia Litwin,et al.  HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5 , 1996, Nature.

[14]  Stephen C. Peiper,et al.  Identification of a major co-receptor for primary isolates of HIV-1 , 1996, Nature.

[15]  N. Bendsøe,et al.  Human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) DNA in Kaposi's sarcoma lesions, AIDS Kaposi's sarcoma cell lines, endothelial Kaposi's sarcoma simulators, and the skin of immunosuppressed patients. , 1996, The American journal of pathology.

[16]  R. Sun,et al.  Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection. , 1996, The New England journal of medicine.

[17]  R. Weiss.  Human herpesvirus 8 in lymphoma and Kaposi's sarcoma: Now the virus can be propagated , 1996, Nature Medicine.

[18]  C. Boshoff,et al.  Kaposi's sarcoma-associated herpesvirus and Kaposi's sarcoma in Africa. Uganda Kaposi's Sarcoma Study Group. , 1996, Archives of internal medicine.

[19]  G. Neufeld,et al.  Interleukin 6 Induces the Expression of Vascular Endothelial Growth Factor (*) , 1996, The Journal of Biological Chemistry.

[20]  J. Diebold,et al.  Kaposi sarcoma-associated herpes-like virus (human herpesvirus type 8) DNA sequences in multicentric Castleman's disease: is there any relevant association in non-human immunodeficiency virus-infected patients? [letter; comment] , 1996 .

[21]  S. Arya,et al.  Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8+ T Cells , 1995, Science.

[22]  C. Boshoff,et al.  Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells , 1995, Nature Medicine.

[23]  L. Appleman,et al.  Dominant‐negative p53 can restore tumorigenicity of L‐929 cells in immunocompetent mice , 1995, International journal of cancer.

[24]  E. Cesarman,et al.  In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences. , 1995, Blood.

[25]  F. Sigaux,et al.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. , 1995, Blood.

[26]  E. Kremmer,et al.  Expression of Epstein‐Barr virus nuclear antigen‐2 (EBNA2) induces CD21/CR2 on B and T cell lines and shedding of soluble CD21 , 1995, European journal of immunology.

[27]  E. Cesarman,et al.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. , 1995, The New England journal of medicine.

[28]  P. Moore,et al.  Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and those without HIV infection. , 1995, The New England journal of medicine.

[29]  J. Ambroziak,et al.  Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients. , 1995, Science.

[30]  C. Fisher,et al.  Kaposi's-sarcoma-associated herpesvirus in HIV-negative Kaposi's sarcoma , 1995, The Lancet.

[31]  L. Montagnier,et al.  Kaposi's sarcoma and new herpesvirus , 1995, The Lancet.

[32]  K. Vousden.  Regulation of the cell cycle by viral oncoproteins. , 1995, Seminars in cancer biology.

[33]  P. Rosenberg,et al.  Changing patterns of Kaposi's sarcoma in Danish acquired immunodeficiency syndrome patients with complete follow-up. The Danish Study Group for HIV Infection (DASHI). , 1995, American journal of epidemiology.

[34]  V. Calvez,et al.  Herpesvirus-like DNA sequences in patients with Mediterranean Kaposi's sarcoma , 1995, The Lancet.

[35]  T. Shenk,et al.  Viruses and apoptosis. , 1995, Current opinion in genetics & development.

[36]  P. Murphy,et al.  Human cytomegalovirus open reading frame US28 encodes a functional beta chemokine receptor. , 1994, The Journal of biological chemistry.

[37]  J. Thompson,et al.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.

[38]  A. Kerlavage,et al.  Analysis of the complete genome of smallpox variola major virus strain Bangladesh-1975. , 1994, Virology.

[39]  V. Beral,et al.  Epidemiologic clues to the etiology of Kaposi's sarcoma. , 1993, AIDS.

[40]  E. Kieff,et al.  Epstein-Barr virus-induced genes: first lymphocyte-specific G protein-coupled peptide receptors , 1993, Journal of virology.

[41]  E. Weissinger,et al.  Effects of interleukin-1, -2, -4, -6, interferon-gamma and granulocyte/macrophage colony stimulating factor on human vascular endothelial cells. , 1993, Immunology letters.

[42]  Albrecht,et al.  Primary structure of the herpesvirus saimiri genome , 1992, Journal of virology.

[43]  R. Weiss,et al.  Human immunodeficiency virus type 2 infection and fusion of CD4-negative human cell lines: induction and enhancement by soluble CD4 , 1992, Journal of virology.

[44]  V. Beral.  Epidemiology of Kaposi's sarcoma. , 1991, Cancer surveys.

[45]  E. Myers,et al.  Basic local alignment search tool. , 1990, Journal of molecular biology.

[46]  G. Forni,et al.  Expression of an exogenous interleukin 6 gene in human Epstein Barr virus B cells confers growth advantage and in vivo tumorigenicity , 1990, The Journal of experimental medicine.

[47]  G. Tosato,et al.  Identification of interleukin-6 as an autocrine growth factor for Epstein-Barr virus-immortalized B cells , 1990, Journal of virology.

[48]  B. Barrell,et al.  Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. , 1990, Current topics in microbiology and immunology.

[49]  K. Arai,et al.  SR alpha promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat , 1988, Molecular and cellular biology.

[50]  J. Sklar,et al.  Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation , 1986, Cell.

[51]  H. Varmus,et al.  Mouse mammary tumor virus DNA in infected rat cells: Characterization of unintegrated forms , 1977, Cell.

[52]  F. Davies.  ALLEGED DEATH FROM TAKING "MORISON'S PILLS." , 1834 .